Natural Resource Partners

Natural Resource Partners L.P. Common Units (NYSE:NRP ) Q1 2025 Results Conference Call May 6, 2025 9:00 AM ET Company Participants Tiffany Sammis - Investor Relations Craig Nunez - President & Chief Operating Officer Chris Zolas - Chief Financial Officer Conference Call Participants John Mason - Aegis Company Operator Hello, and welcome to the Natural Resource Partners L.P.» Mehr auf seekingalpha.com

In addition to securing new contracts from the Ohio Department of Natural Resources covering 10 well sites to be remediated, Zefiro subsidiary Plants & Goodwin, Inc. also earned a collection of projects from two private-sector customers covering an additional 15 well sites, solidifying the Company's increasing commercial footprint in Ohio and Pennsylvania. In addition to securing new contracts from the Ohio Department of Natural Resources covering 10 well sites to be remediated, Zefiro subsidiary Plants & Goodwin, Inc. also earned a collection of projects from two private-sector customers covering an additional 15 well sites, solidifying the Company's increasing commercial footprint in Ohio and Pennsylvania.» Mehr auf globenewswire.com

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will present a poster featuring preclinical data for ATYR2810, a monoclonal antibody targeting neuropilin-2 (NRP2), at the American Association for Cancer Research (AACR) Annual Meeting 2025, which is being held April 25 – 30, 2025, in Chicago, IL. “Aggressive cancers like glioblastoma multiforme (GBM) continue to show drug resistance, and the efficacy of current immunotherapies may be limited due to immunosuppressive myeloid cells in the tumor microenvironment that contribute to drug resistance.» Mehr auf globenewswire.com